Clinical Trial Update: Phase I Multiple-Ascending Dose (Japan) [Phase 1]

View source ↗

Summary

A Phase I multiple-ascending-dose study in Japan for Type 2 diabetes completed, sponsored by AstraZeneca.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED